Page 7 of articles about vaccine

US: APHIS to invest $27 million in foot-and-mouth disease vaccine in case of outbreak

This new program adds to the nation’s level of protection against this devastating disease. In the event of an outbreak, officials would decide if and how to use the available vaccine.

Home

HealthArticle

PCV-2d, PCV-2b, PCV-2a. How important are the differences between genotypes for veterinarians?

Serious problems occurred much less frequently with genotype a than with genotype b. Why did the frequency of these genotypes change?

Home

1 1

HealthPress releases

Boehringer Ingelheim’s classical swine fever live vaccine approved

Ingelvac^® CSF MLV, the first classical swine fever live vaccine jointly developed by a multinational company and Chinese research institutes.

Home

HealthPress releases

Pirbright ASF vaccine protects pigs from developing severe disease

100 percent of pigs immunised with the new vaccine survived a lethal dose of ASF virus.

Home

HealthArticle

PRRS - Why can't I achieve long-term stability on my farm?

Its high survivability in the environment, a long infective period, limited cross-protection, strains with different pathogenicity, and lateral infections make stabilization difficult.

Home

Figure 1. Generation and virulence evaluation of different gene-deleted African swine fever viruses (ASFVs). Schematic representation of the gene(s) and region(s) deleted in each gene-deleted ASFV. The deleted gene segments were replaced with the p72eGFP, eGFP, or p72mCherry reporter gene cassette as indicated. The virus-infected primary porcine alveolar macrophages expressing different fluorescence are shown on the right of the panel. Nucleotide positions indicating the boundaries of the deletion relative to the ASFV HLJ/18 genome are indicated.

6 1

HealthArticle

What can we expect from the new ASF vaccine developed in China?

This vaccine looks promising, but... are we going to see it in Europe?

Home

Colourised transmission electron micrograph of a Nipah Virus particle (green) near the edge of an infected cell (blue). Image captured and colour-enhanced at the NIAID Integrated Research Facility in Fort Detrick, Maryland. Credit: NIAID

HealthPress releases

Pirbright shows new Nipah vaccines create ‘impressive’ immune response

Two new potential vaccines against Nipah virus developed by the University of Parma generate a strong immune response in pigs, and could be the key to preventing this deadly, zoonotic disease.

Home

HealthAbstract

Highly effective vaccine against ASFV

The gene-deleted HLJ/-18-7GD virus is a safe and effective vaccine against ASFV, and could play an important role in controlling the spread of ASFV.

Home

HealthNews

Increasing Canada's preparedness for ASF with the University of Saskatchewan's VIDO-InterVac

International Vaccine Centre, VIDO-InterVac will commence work in January to develop and test vaccines and antivirals for ASF, seeking to protect the pork industry in Canada and worldwide.

Home

HealthPress releases

Boehringer Ingelheim introduces DiaTEC purification technology for Ingelvac CircoFLEX^®

Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine. With DiaTEC diafiltration technology, Ingelvac CircoFLEX® becomes the first and only non-virucidal PCV2 vaccine for improved capabilities to be freshly mixed on farm.

Home

HealthHumor

What you didn't know about live vaccines

In many articles we have explained the difference between killed, live, modified, and subunit vaccines... but this is something totally new.

Home

HealthPress releases

Salmonella vaccine now available to UK and Irish pig producers

Pig producers in the UK and Ireland have a new means of defense in the fight against salmonella with the launch of a highly effective salmonella vaccine that has already been well-proven in Germany and Poland.

Home

HealthArticle

Acclimation strategies in gilts to control Mycoplasma hyopneumoniae: what strategies can we use?

Exposure methods: natural, intranasal, intra-tracheal, aerosol or vaccination.

Home

HealthPress releases

Pirbright grants licence for new Foot-and-Mouth disease vaccine

Instead of traditional methods of vaccine development, using infectious virus as its basis, they synthetically created empty protein shells to imitate the protein coat that forms the strong outer layer of the virus.

Home

HealthPress releases

Prevtec Microbia to be Acquired by Elanco

Deal supports development of Prevtec Microbia’s pipeline and product expansion

Home

HealthPress releases

Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries

Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.